United States Biotechnology & Medical Research

Fibrobiologics Inc (FBLG)

Track

Fibrobiologics Inc. experienced multiple insider acquisitions during early March 2026. Key executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Scientific Officer, purchased shares between March 2 and March 4. These transactions represent the most recent activity, as no further trades occurred within the last three months.
Ticker: FBLG Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fibrobiologics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 4 Mar 2026
Value US$4,231,245.24 | Price 41.84 | Shares 44,847 (-42.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04 B Purchase
2.6
Khoja Hamid

Chief Scientific Officer

Officer
44,847 -42.9%
41.84
US$4,231,245 		44,847 -42.9% 41.84 US$4,231,245
2026-03-04 2026-03-04 B Purchase
3.8
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
9,416 -13.0%
146.58
US$2,535,787 		9,416 -13.0% 146.58 US$2,535,787
2026-03-04 2026-03-03 B Purchase
3.8
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
32,314 +18.5%
163.41
US$937,577 		32,314 +18.5% 163.41 US$937,577
2026-03-04 2026-03-02 B Purchase
3.8
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
17,428 +0.3%
0.35
US$6,152 		17,428 +0.3% 0.35 US$6,152
2026-03-03 2026-03-02 B Purchase
0.5
Davis Jason

Chief Financial Officer

Officer
70,000 +inf%
0.41
US$28,973 		70,000 +inf% 0.41 US$28,973
2026-03-02 2026-02-27 B Purchase
1.7
GARCIA RUBEN A

General Counsel

Officer
40,000 +28.6%
0.33
US$13,056 		40,000 +28.6% 0.33 US$13,056
2025-12-12 2025-12-11 B Purchase
1.7
GARCIA RUBEN A

General Counsel

Officer
140,000 +inf%
0.34
US$47,600 		140,000 +inf% 0.34 US$47,600
2025-05-27 2025-05-27 B Purchase
2.6
Khoja Hamid

Chief Scientific Officer

Officer
20,000 +177.8%
0.84
US$16,800 		20,000 +177.8% 0.84 US$16,800
2024-08-12 2024-08-12 B Purchase
2.6
Khoja Hamid

Chief Scientific Officer

Officer
10,000 +800.0%
1.90
US$19,000 		10,000 +800.0% 1.90 US$19,000
2024-08-12 2024-08-12 B Purchase
3.8
O'HEERON PETE

Chief Executive Officer

Executive Director
8,500 +0.1%
1.91
US$16,269 		8,500 +0.1% 1.91 US$16,269
Explore more

More insider trading research around Fibrobiologics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America